Boston
Dana McSherry is the Boston lead of McDermott Will & Schulte’s Litigation Practice Group and co-leads the firm’s False Claims Act (FCA) practice. She advises healthcare and life sciences companies in criminal and civil government enforcement matters and in related civil litigation, including civil False Claims Act (FCA) litigation. Dana guides clients through all aspects of civil and criminal investigations relating to Medicare and Medicaid billing and other government contracting issues, including negotiating with the government and managing clients’ responses to civil investigative demands and large-scale investigative subpoenas. She also assists clients in conducting internal investigations and counsels clients across the healthcare industry on compliance and risk management issues.
- Representing pharmaceutical company in state and federal investigations relating to patient support services
- Represented pharmaceutical company in industry-wide investigation by the US Attorney’s Office in Massachusetts and the DOJ into donations to charitable assistance foundations that provide financial assistance to Medicare patients
- Successfully defended a pharmacist charged with RICO, mail fraud, and Food, Drug and Cosmetics Act violations; following a two-month trial, the client was acquitted of all charges
- Best Lawyers in America, Healthcare Law (2023-2026), Criminal Defense: White-Collar, Litigation – Health Care, 2026
- Thomson Reuters, Stand-out Lawyer – independently rated lawyers, 2025-2026
- Chambers USA, Litigation: White-Collar Crime & Government Investigations, 2025-2026
- Boston Bar Association
- Women’s Bar Association
- Boston College Law School, JD
- University of Notre Dame, BA, magna cum laude
- Massachusetts
- US District Court for the District of Massachusetts
Insights, News & Events
